CL
CRL icon

Choreo LLC’s Charles River Laboratories CRL Stock Holding History

Choreo LLC’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$381K Sell
2,208
-10
-0.5% -$1.85K ﹤0.01% 1104
2025
Q4 		$448K Sell
2,218
-93
-4% -$16.9K 0.01% 973
2025
Q3 		$362K Buy
2,311
+277
+14% +$44K ﹤0.01% 1116
2025
Q2 		$309K Buy
2,034
+153
+8% +$20.4K ﹤0.01% 1154
2025
Q1 		$283K Buy
+1,881
New +$315K ﹤0.01% 1123

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Choreo LLC's CRL Position: Q1 2026 in Review

Choreo LLC reduced its Charles River Laboratories (CRL) stake by 0.45% in Q1 2026, selling an estimated $1.85K and leaving 2,208 shares worth $381K. The position accounts for ﹤0.01% of the portfolio, ranked #1104.

Choreo LLC first reported a position in CRL in Q1 2025 and has held it in 5 quarters since. The position peaked at $448K in Q4 2025. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Choreo LLC held 2,208 shares of Charles River Laboratories worth $381K as of Q1 2026.
  • Choreo LLC sold 10 Charles River Laboratories shares in Q1 2026, an estimated $1.85K.
  • Charles River Laboratories made up ﹤0.01% of Choreo LLC's portfolio in Q1 2026, its #1104 holding.
  • Choreo LLC first reported a position in Charles River Laboratories in Q1 2025 and has held it in 5 quarters since.
  • Choreo LLC's Charles River Laboratories position peaked at $448K in Q4 2025.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.